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No association of serotonin transporter gene variation with
sudden infant death syndrome (SIDS) in Caucasians
Abstract
Genetic studies on SIDS have been motivated by clinical, epidemiological, and/or neuropathological
observations made of SIDS victims. One of the candidate genes is the serotonin transporter (5-HTT)
gene, based on decreased serotonergic receptor binding observed in the brain-stems of SIDS victims.
Two polymorphisms in the regulatory region of the 5-HTT gene differentially modulate gene expression
(promoter, intron 2). The promoter allelic variants long (L) and extra long (XL) and the intron 2
12-repeat allele seem to be associated with SIDS; however, the 5-HTT promoter allele distribution
varies widely by ethnicity. We investigated the DNA of 145 Caucasian SIDS cases and 58 controls and
could find no significant association between our Caucasian SIDS cases and controls either for the
promoter L allele and the intron 2 12-repeat allele, or for the combined L-12 haplotype as well as the L-
or 12-containing genotypes.
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Abstract 
 
Genetic studies on SIDS have been motivated by clinical, epidemiological, and/or neuro-
pathological observations made of SIDS victims. One of the candidate genes is the serotonin 
transporter (5-HTT) gene, based on decreased serotonergic receptor binding observed in the 
brain-stems of SIDS victims.  Two polymorphisms in the regulatory region of the 5-HTT gene 
differentially modulate gene expression (promoter, intron 2). The promoter allelic variants 
long (L) and extra long (XL) and the intron 2 12-repeat allele seem to be associated with 
SIDS; however, the 5-HTT promoter allele distribution varies widely by ethnicity. We investi-
gated the DNA of 145 Caucasian SIDS cases and 58 controls and could find no significant 
association between our Caucasian SIDS cases and controls either for the promoter L-allele 
and the intron 2 12-repeat allele, or for the combined L-12 haplotype as well as the L- or 12- 
containing genotypes. 
 
Keywords: SIDS, 5-HTT, serotonin transporter, promoter, intron 2  
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1. Introduction 
 
Serotonin pathways have been of particular interest in SIDS research because serotonin (5-
HT) influences a broad range of physiological systems including the regulation of breathing, 
the cardiovascular system, temperature, and the sleep-wake cycle. Recent studies have 
identified abnormalities in the development and function of medullary 5-HT pathways in post-
mortem SIDS brains [1, 2, 3, 4]. Two functional polymorphisms associated with SIDS risk 
have been identified in the 5-HT transporter gene (5-HTT, SLC6A4). Initially, Narita and co-
workers demonstrated an association between a promoter polymorphism in 5-HTT (allelic 
variants S (short), L (long) and rarely XL (extra long), corresponding to 14, 16 and less com-
monly, 18 or 20 repetitive elements) and the risk of SIDS in the Japanese population, be-
cause the L and XL alleles were found more frequently in SIDS victims than in age-matched 
control participants [5]. Two years later the research group led by Weese-Mayer confirmed 
these results in a cohort of 43 African American and 44 Caucasian SIDS cases [6], while an-
other three years later Paterson et al. were unable to confirm them in a cohort of 31 SIDS 
cases [4]. A polymorphic variable number of tandem repeat (VNTR) in intron 2 of 5-HTT con-
taining 9, 10 or 12 copies of a 16-17 bp repeat sequence [7] has also been shown to differ-
entially regulate 5-HTT expression, with the 12 repeat allele being the more effective pro-
moter [8]. Weese-Mayer et al. found a positive association with the intron 2 genotype distri-
bution in 44 African American SIDS cases when compared to controls, but not in the Cauca-
sian subgroup (46 SIDS cases) [9]. Our investigations of the two polymorphisms (promoter 
and intron 2) of the 5-HTT gene in a cohort of 145 Swiss SIDS cases were motivated by 
these observations and aimed to test the reported association between the 5-HTT gene and 
SIDS in a substantially larger data set of Caucasian SIDS cases. In the meantime Opdal et 
al. have published the results of their study of 163 Norwegian SIDS cases and were able to 
confirm previous findings that the L allele and L/L genotype in the promoter of the 5-HTT 
gene are associated with SIDS, while, for intron 2, there were no differences between SIDS 
cases and controls [10]. 
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2. Material and method 
 
2.1. Material (Study Population) 
Our study population consists of 145 SIDS cases (37 cases of group I (no pathological find-
ings at all): median age 15.6 months, range 4-48 weeks, 23 male/ 14 female; 108 cases of 
group II (changes or abnormalities not sufficient to cause death): median age 18.2 months, 
range 2-47 weeks, 66 male/ 42 female) classified according to the generally accepted inter-
national definitions of SIDS including the current San Diego definition [11] and 58 age- and 
gender-matched controls (deceased infants under 1 year of age with defined causes of 
death: median age 18.0 months, range 1-54 weeks, 35 male/ 23 female). The SIDS cases 
and controls were collected and investigated at the Institute of Legal Medicine, University of 
Zurich, in the years 1985-2006; nearly all of them were diagnosed by the same examiner (an 
expert in SIDS pathology).  Almost all subjects were Caucasians from Switzerland. 
 
2.2. Method (Genetic testing and Statistics)  
DNA was extracted from alcohol-fixed paraffin-embedded tissue (kidney, tongue, muscle) 
according to standard protocols. The DNA-regions of interest were amplified using specific 
fluorescence-labelled primers. For the investigation of the promoter polymorphism, primers 
were designed using the Primer3 online software (http://frodo.wi.mit.edu/): 5’FAM-GCC AGC 
ACC TAA CCC CTA AT-3’ and 5’-AGA GGG ACT GAG CTG GAC AA-3’. The GC-rich PCR 
System, dNTPack (Roche Diagnostics AG, Rotkreuz, Switzerland) was used for the PCR re-
action in accordance with the manufacturer's protocol in a total reaction volume of 25 µl. The 
primer concentration was 0.2 µM. The amplification conditions were as follows: initial denatu-
ration was 95°C for 3 min., followed by 35-50 cycles of 94°C 30s, 58°C 30s, 72°C 40s and 
the final elongation at 72°C for 30 min. The two alleles S and L had a length of 468 bp and 
503 bp, respectively. For the investigation of the intron 2 polymorphism, primers were ad-
opted from the literature [7]: 5’FAM-GTC AGT ATC ACA GGC TGC GAG-3’ and 5’-TGT TCC 
TAG TCT TAC GCC AGT G-3’. The PCR reaction mixture consisted of 10x PCR Gold buffer, 
1 mM MgCl2, 0.8 mM dNTPs, 1.25 U AmpliTaq Gold DNA-Polymerase (all from Applied Bio-
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systems, Rotkreuz, Switzerland) in a total reaction volume of 25 µl. The primer concentration 
was 0.33 µM. The amplification conditions were as follows: initial denaturation was 95°C for 
15 min., followed by 35 cycles of 95°C 30s, 56°C 30s, 72°C 40s and the final elongation at 
72°C for 30 min. The three alleles 9, 10 and 12 had a length of 248 bp, 265 bp and 298 bp, 
respectively. PCR products were separated and detected using a Genetic Analyzer 310 (Ap-
plied Biosystems). 
 
Haplotype frequencies were estimated in the SIDS and control groups separately using a 
statistical method to reconstruct haplotypes from genotype data at linked loci: software 
PHASE, version 2.1 [12, 13].  The chi-square test was used to compare the frequencies of 
the different polymorphisms between SIDS cases and controls 
(http://home.ubalt.edu/ntsbarsh/Business-stat/otherapplets/Catego.htm). For tables with low cell 
counts, Fisher's exact test was applied instead. The statistical programming language R (The 
R Foundation for Statistical Computing, version 2.7.1) was used for these calculations.  
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3. Results 
 
In the promoter, no differences in allele and genotype distribution were found either between 
SIDS group I and controls (p = 0.42 and p = 0.65, respectively), or between SIDS groups I + 
II and controls (p = 0.34 and p = 0.60, respectively) (Table 1). The L/L genotype was not 
found to occur more frequently in SIDS cases (groups I + II) than in controls (p = 0.31, L/L 
genotype versus S/S + S/L), and the rare XL allele variant was not present in the whole study 
population. We also did not observe a deficiency of the S/S genotype in SIDS cases (groups 
I + II) versus controls (p = 0.62, S/S genotype versus S/L + L/L).  
 
The allele and genotype distribution for the intron 2 polymorphism does not differ significantly 
either between SIDS group I and controls (p = 0.43 and p = 0.32, respectively), or between 
SIDS groups I + II and controls (p = 0.64 and p = 0.42, respectively) (Table 1). Also, the 12 
allele and 12/12 genotype were not significantly increased in SIDS (groups I + II) versus con-
trols (p = 0.75, 12 allele versus 9 + 10; and p = 0.27, 12/12 genotype versus rest). 
 
The analysis of the combined promoter and intron 2 genotypes revealed no differences for 
the L/L 12/12 genotype in comparison with the other genotypes in SIDS (groups I + II) and 
controls (p = 0.30) (Table 2). Furthermore, there were no differences in haplotype frequen-
cies between SIDS group I and controls (p = 0.82) or SIDS groups I + II and controls (p = 
0.88) (Table 2). No higher frequency of the L-12 haplotype could be found in SIDS (groups I 
+ II) compared to controls (p = 0.47, L-12 haplotype in comparison with the other haplo-
types).  
 
 
7 
4. Discussion 
 
In our case-control study of 145 Caucasian SIDS cases compared to 58 age- and gender-
matched controls, we could not confirm previous findings that the L allele and L/L genotype 
in the promoter polymorphism of the 5-HTT gene are associated with SIDS [5, 6, 10]. In this 
study only 53.4 % of the SIDS cases had a long allele and 29.0 % the L/L genotype, com-
pared to 58.6 % and 36.2 %, respectively, in the controls (Table 1). Our control group there-
fore had even higher L allele and L/L genotype frequencies than the SIDS groups (I+II). The 
rare XL allele variant, which is uniquely present in individuals of African origin and has also 
been identified as an important risk factor for SIDS, was not found at all in our study popula-
tion. As has been shown, there is ethnic variation in the L allele frequency of the 5-HTT pro-
moter, ranging from very low in the Japanese population (13.5%) [5] to high in African Ameri-
cans (73.9%) [6]. Nevertheless significant differences in L allele and L/L genotype frequen-
cies between SIDS cases and controls were found in nearly all ethnicities analyzed (African 
Americans, Japanese, Caucasians). Only Paterson and colleagues did not find a difference 
in frequency distribution of the different genotypes in a small SIDS study population (31 SIDS 
cases and 10 controls) [4]. As we have been able to show, these inconsistent findings cannot 
be explained solely by the smallness of the data set, as previously assumed. Furthermore, 
the Caucasian population seems to be homogeneous, with the consequence that no ethnic 
differences between the Swiss, the Norwegian and the American Caucasians are expected 
[14, 15]. The discrepancy between the results may, however, be due to a non-uniform classi-
fied SIDS study population within the different working groups. In concordance with results 
from all other Caucasian SIDS study populations [9, 10], we were also unable to find differ-
ences between the intron 2 allele and genotype frequencies as well as between the com-
bined promoter – intron 2 haplotypes and genotypes in SIDS cases compared to controls 
(Table 2). Finally, it follows from our results that there is no evidence for a definite associa-
tion of serotonin transporter gene variation with SIDS in Caucasians; therefore the promoter 
and intron 2 polymorphisms are not likely to be potent risk factors for SIDS in this ethnicity 
group. 
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Table 1 
Allele and genotype distribution for the Promoter and the Intron 2 polymorphism at the 5-HTT 
locus in SIDS cases and controls 
 
 SIDS group I SIDS groups I+II Controls 
 n % n % n % 
Promoter       
Allele       
S 35 47.3 135 46.6 48 41.4 
L 39 52.7 155 53.4 68 58.6 
Genotype       
S/S 8 21.6 32 22.0 11 19.0 
S/L 19 51.4 71 49.0 26 44.8 
L/L 10 27.0 42 29.0 21 36.2 
Intron 2       
Allele       
9 3 4.0 8 2.8 1 0.8 
10 27 36.5 107 36.9 43 37.1 
12 44 59.5 175 60.3 72 62.1 
Genotype       
9/10 1 2.7 2 1.4 0 0.0 
9/12 2 5.4 6 4.1 1 1.7 
10/10 5 13.5 21 14.5 12 20.7 
10/12 16 43.3 63 43.4 19 32.8 
12/12 13 35.1 53 36.6 26 44.8 
 
Table 2 
Combined genotypes and haplotypes at the 5-HTT locus in SIDS cases and controls 
 
Promoter Intron 2 SIDS group I SIDS groups I+II Controls 
  n % n % n % 
Genotype        
S/S 9/10 + 10/10 0 0.0 1 0.7 0 0.0 
S/S 9/12 + 10/12 3 8.1 11 7.6 2 3.5 
S/S 12/12 5 13.5 20 13.8 9 15.5 
S/L 9/10 + 10/10 2 5.4 8 5.5 4 6.9 
S/L 9/12 + 10/12 10 27.1 36 24.8 10 17.2 
S/L 12/12 7 18.9 27 18.6 12 20.7 
L/L 9/10 + 10/10 4 10.8 14 9.7 8 13.8 
L/L 9/12 + 10/12 5 13.5 22 15.2 8 13.8 
L/L 12/12 1 2.7 6 4.1 5 8.6 
Haplotype       
S 9 + 10 3 9.5 14 9.3 4 6.6 
S 12 14 37.8 54 37.3 20 34.8 
L 9 + 10 12 31.0 44 30.4 18 31.3 
L 12 8 21.7 33 23.0 16 27.3 
 
